Literature DB >> 8551614

Mutations of basic amino acids of NCp7 of human immunodeficiency virus type 1 affect RNA binding in vitro.

E Schmalzbauer1, B Strack, J Dannull, S Guehmann, K Moelling.   

Abstract

The nucleocapsid (NC) protein of human immunodeficiency virus type 1 is required for packaging of viral RNA and for virion assembly. It contains two clusters of basic amino acids, consisting of five and four amino acid residues, flanking the first of its two zinc fingers. These amino acid residues have been mutagenized to neutral ones individually, as well as in various combinations, by site-directed mutagenesis. Wild-type NCp7 and the mutant proteins were expressed as recombinant proteins in Escherichia coli, with six histidines as tags at their amino termini in order to allow efficient purification. The purified proteins were analyzed for RNA binding in vitro with human immunodeficiency virus type 1 5' leader RNA transcribed in vitro. Assays comprised Northwestern blots at various salt concentrations and filter binding tests which allowed determination of the dissociation constants of the various mutants. The results indicated that mutations of the amino acid R-7 and of R-32 and K-33 were more critical for RNA binding than other mutations. Mutation of the other amino acid residues reduced the binding affinity in proportion to the number of mutations. Mutation of seven of the nine basic amino acid residues reduced the binding of RNA by 50- to 90-fold.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8551614      PMCID: PMC189878     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Protein enhancement of hammerhead ribozyme catalysis.

Authors:  Z Tsuchihashi; M Khosla; D Herschlag
Journal:  Science       Date:  1993-10-01       Impact factor: 47.728

2.  The polypurine tract, PPT, of HIV as target for antisense and triple-helix-forming oligonucleotides.

Authors:  S Volkmann; J Dannull; K Moelling
Journal:  Biochimie       Date:  1993       Impact factor: 4.079

3.  Specific binding of human immunodeficiency virus type 1 gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays.

Authors:  R D Berkowitz; J Luban; S P Goff
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

4.  Conformational behaviour of the active and inactive forms of the nucleocapsid NCp7 of HIV-1 studied by 1H NMR.

Authors:  N Morellet; H de Rocquigny; Y Mély; N Jullian; H Déméné; M Ottmann; D Gérard; J L Darlix; M C Fournie-Zaluski; B P Roques
Journal:  J Mol Biol       Date:  1994-01-07       Impact factor: 5.469

5.  Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein.

Authors:  T Dorfman; J Luban; S P Goff; W A Haseltine; H G Göttlinger
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

6.  The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent.

Authors:  R J Gorelick; D J Chabot; A Rein; L E Henderson; L O Arthur
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

7.  Facilitation of hammerhead ribozyme catalysis by the nucleocapsid protein of HIV-1 and the heterogeneous nuclear ribonucleoprotein A1.

Authors:  E L Bertrand; J J Rossi
Journal:  EMBO J       Date:  1994-06-15       Impact factor: 11.598

8.  An RNA chaperone activity of non-specific RNA binding proteins in hammerhead ribozyme catalysis.

Authors:  D Herschlag; M Khosla; Z Tsuchihashi; R L Karpel
Journal:  EMBO J       Date:  1994-06-15       Impact factor: 11.598

9.  RNA annealing activities in HeLa nuclei.

Authors:  D S Portman; G Dreyfuss
Journal:  EMBO J       Date:  1994-01-01       Impact factor: 11.598

10.  Specific binding of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues.

Authors:  J Dannull; A Surovoy; G Jung; K Moelling
Journal:  EMBO J       Date:  1994-04-01       Impact factor: 11.598

View more
  44 in total

1.  Identification of residues of the Moloney murine leukemia virus nucleocapsid critical for viral DNA synthesis in vivo.

Authors:  J Gonsky; E Bacharach; S P Goff
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

2.  Human immunodeficiency virus types 1 and 2 differ in the predominant mechanism used for selection of genomic RNA for encapsidation.

Authors:  J F Kaye; A M Lever
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

3.  RNA incorporation is critical for retroviral particle integrity after cell membrane assembly of Gag complexes.

Authors:  Shainn-Wei Wang; Anna Aldovini
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  Determinants of the human immunodeficiency virus type 1 p15NC-RNA interaction that affect enhanced cleavage by the viral protease.

Authors:  N Sheng; S C Pettit; R J Tritch; D H Ozturk; M M Rayner; R Swanstrom; S Erickson-Viitanen
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

5.  Nucleocapsid-RNA interactions are essential to structural stability but not to assembly of retroviruses.

Authors:  Shainn-Wei Wang; Kristin Noonan; Anna Aldovini
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

6.  Role of the C terminus of foamy virus Gag in RNA packaging and Pol expression.

Authors:  Carolyn R Stenbak; Maxine L Linial
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

7.  Basic residues in the nucleocapsid domain of Gag are critical for late events of HIV-1 budding.

Authors:  Vincent Dussupt; Paola Sette; Nana F Bello; Melodi P Javid; Kunio Nagashima; Fadila Bouamr
Journal:  J Virol       Date:  2010-12-15       Impact factor: 5.103

8.  Roles of matrix, p2, and N-terminal myristoylation in human immunodeficiency virus type 1 Gag assembly.

Authors:  Y Morikawa; D J Hockley; M V Nermut; I M Jones
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

9.  Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA.

Authors:  A Cimarelli; S Sandin; S Höglund; J Luban
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

10.  Effect of dimerizing domains and basic residues on in vitro and in vivo assembly of Mason-Pfizer monkey virus and human immunodeficiency virus.

Authors:  Karolína Bohmová; Romana Hadravová; Jitka Stokrová; Roman Tuma; Tomás Ruml; Iva Pichová; Michaela Rumlová
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.